Related Experiment Videos
Cancer prevention in the year 2025: an anticipation
1Chao Family Comprehensive Cancer Center, University of California, Irvine, CA, USA. flmeyske@uci.edu
European Journal of Cancer (Oxford, England : 1990)
|September 7, 2000
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Antagonism of p66shc by melanoma inhibitory activity.
Cell death and differentiation·2007
HPV infection and number of lifetime sexual partners are strong predictors for 'natural' regression of CIN 2 and 3.
British journal of cancer·2003
Development of Bowman-Birk inhibitor for chemoprevention of oral head and neck cancer.
Annals of the New York Academy of Sciences·2002
Local therapy to recurrent/metastatic foci augments the benefit of immune checkpoint inhibitors in nasopharyngeal carcinoma.
European journal of cancer (Oxford, England : 1990)·2026
Association of immune and proliferation gene signatures and stromal tumor-infiltrating lymphocytes with clinical outcomes in patients with stage I triple-negative breast cancer.
European journal of cancer (Oxford, England : 1990)·2026
Decluttering chemotherapy agents for HER2+early breast cancer: Do we still need carboplatin?
European journal of cancer (Oxford, England : 1990)·2026
Natural history and treatment outcomes in aggressive angiomyxoma: A single institution experience.
European journal of cancer (Oxford, England : 1990)·2026
Diagnostic pitfalls and unmet needs in neuroendocrine neoplasms: The added value of collegial expert pathology review through the national TENpath network.
European journal of cancer (Oxford, England : 1990)·2026
Twenty-five years survival of primary central nervous system lymphomas treated with the C5R regimen.
European journal of cancer (Oxford, England : 1990)·2026